Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Hologic Inc (HOLX.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-03-25	76.05	-	No Rating
2022-07-19	70.49	73.00	Neutral
2022-07-28	70.78	77.00	Neutral
2023-02-02	84.44	88.00	Neutral
2023-05-01	87.67	93.00	Neutral
2023-07-31	79.42	91.00	Neutral
2023-11-15	72.01	78.00	Neutral
2024-02-01	74.41	79.00	Neutral
2024-05-02	75.91	81.00	Neutral
2024-07-29	79.64	84.00	Neutral
2024-11-04	83.72	90.00	Neutral
2024-12-15	73.65	84.00	Neutral
2025-02-05	72.80	80.00	Neutral
2025-05-01	57.28	65.00	Neutral

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.